Literature DB >> 1684818

Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.

R L Webb1, B W Barclay, S C Graybill.   

Abstract

The hemodynamic responses to 5'-N-ethylcarboxamide adenosine (NECA), a nonselective adenosine agonist, were compared to those elicited by the sodium salt of 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamido adenosine (CGS 21680C) and N6-2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl adenosine (CGS 24012), two structurally dissimilar selective A2 agonists in conscious spontaneously hypertensive rats (SHR). Dose-related reductions in mean arterial pressure occurred after bolus administration of NECA, CGS 21680C and CGS 24012. Dose-dependent tachycardia was seen with both CGS 21680C and CGS 24012, whereas NECA produced a biphasic response on heart rate. At high doses (3 and 10 micrograms/kg), NECA evoked an immediate and dramatic fall in heart rate, followed by a more gradual and long-lasting tachycardia. At equihypotensive doses, both CGS 21680C and CGS 24012 produced significant increases in cardiac output, but NECA had no effect. Although each of the adenosine agonists reduced total peripheral resistance, the greatest change was produced by CGS 21680C. Hindquarter, renal and mesenteric vascular resistances were significantly reduced by both CGS 21680C and CGS 24012, whereas only mesenteric vascular resistance was reduced with NECA. CGS 24012 reduced renal vascular resistance to the greatest extent and produced a concomitant significant increase in renal blood flow. Marked elevation in plasma renin activity occurred with CGS 24012 and CGS 21680C, whereas no change was seen after NECA. The hemodynamic responses to NECA, CGS 21680C and CGS 24012 were significantly reduced by the adenosine antagonist, 8-(p-sulfophenyl) theophylline, suggesting that these agents act through stimulation of adenosine receptors in the conscious SHR. Furthermore, blockade of the beta adrenergic receptor with metoprolol (1 mg/kg, i.v.) significantly attenuated the increase in heart rate produced by NECA, CGS 21680C and CGS 24012. The cardiovascular pattern of responses to the two selective A2 agonists, CGS 21680C and CGS 24012, are distinct from those of NECA, the nonselective adenosine agonist. The responses to both CGS 21680C and CGS 24012 indicate that systemic vasodilation, with resultant cardioexcitation and stimulation of renin release, are the predominant hemodynamic effects of selective A2 agonists in the conscious SHR. In contrast, the cardiovascular effects produced by NECA are mediated by activation of both A1 and A2 receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684818

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.

Authors:  R A Mathôt; E M Van der Wenden; W Soudijn; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

2.  Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.

Authors:  R A Mathoôt; W Soudijn; D D Breimer; A P Ijzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

3.  Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.

Authors:  R A Mathôt; A Cleton; W Soudijn; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

4.  Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.

Authors:  R A Mathôt; J M Gubbens-Stibbe; W Soudijn; K A Jacobson; A P Ijzerman; M Danhof
Journal:  J Pharmacol Exp Ther       Date:  1995-10       Impact factor: 4.030

5.  Quantifying Effects of Pharmacological Blockers of Cardiac Autonomous Control Using Variability Parameters.

Authors:  Renata Miyabara; Karsten Berg; Jan F Kraemer; Ovidiu C Baltatu; Niels Wessel; Luciana A Campos
Journal:  Front Physiol       Date:  2017-01-23       Impact factor: 4.566

6.  Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum.

Authors:  Kavya Prasad; Erik F J de Vries; Jürgen W A Sijbesma; Lara Garcia-Varela; Daniel A Vazquez-Matias; Rodrigo Moraga-Amaro; Antoon T M Willemsen; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Pharm       Date:  2022-07-18       Impact factor: 5.364

7.  The discovery of a selective and potent A2a agonist with extended lung retention.

Authors:  Annika B M Åstrand; Eva Lamm Bergström; Hui Zhang; Lena Börjesson; Therese Söderdahl; Cecilia Wingren; Anne-Helene Jansson; Amir Smailagic; Camilla Johansson; Håkan Bladh; Igor Shamovsky; Anders Tunek; Tomas Drmota
Journal:  Pharmacol Res Perspect       Date:  2015-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.